Identifying and classifying biomedical perturbations in text by Rodriguez-Esteban, Raul et al.
Published online 12 December 2008 Nucleic Acids Research, 2009, Vol. 37, No. 3 771–777
doi:10.1093/nar/gkn986
Identifying and classifying biomedical perturbations
in text
Raul Rodriguez-Esteban*, Phoebe M. Roberts and Matthew E. Crawford
Pfizer Research Technology Center, 620 Memorial Dr., Cambridge, MA 02139, USA
Received September 11, 2008; Revised November 11, 2008; Accepted November 21, 2008
ABSTRACT
Molecular perturbations provide a powerful toolset
for biomedical researchers to scrutinize the contrib-
utions of individual molecules in biological systems.
Perturbations qualify the context of experimental
results and, despite their diversity, share properties
in different dimensions in ways that can be forma-
lized. We propose a formal framework to describe
and classify perturbations that allows accumulation
of knowledge in order to inform the process of bio-
medical scientific experimentation and target
analysis. We apply this framework to develop a
novel algorithm for automatic detection and charac-
terization of perturbations in text and show its
relevance in the study of gene–phenotype associa-
tions and protein–protein interactions in diabetes
and cancer. Analyzing perturbations introduces a
novel view of the multivariate landscape of biologi-
cal systems.
INTRODUCTION
In the early days of biological research, mutations that
caused discernable phenotypes were the primary tool for
understanding how a biological system worked—in the
absence of a mutation a gene was invisible. Today, biolo-
gists are armed with a whole arsenal of tools to regulate
gene, mRNA, and protein abundance and activity,
thereby promoting the discovery of mechanisms and
how a system gone awry can lead to disease (1). Among
these are tools for suppressing the activity of a gene or
gene product (e.g. site-directed mutagenesis, RNA inter-
ference, small molecule inhibitors) or enhancing activity
(e.g. activating mutations or receptor agonist). Markedly
diﬀerent approaches can be used to perturb biological
systems with similar eﬀects. For instance, interfering
with protein activity using small-molecule inhibitors
should have a phenotype similar to reducing the abun-
dance of the corresponding mRNA with anti-sense
oligonucleotides (2). Likewise, similar responses are
expected whether increases in intracellular protein concen-
tration are achieved via an inducible promoter or by addi-
tion of recombinant protein (3). As such, perturbations
form the core of understanding how biological systems
work, how diseases arise, and how they can be treated.
Any serious attempt to analyze a biological process
starts by identiﬁcation and characterization of perturba-
tions that have been used in prior work. This task requires
a framework that can be systematically applied and that is
amenable to both manual and automatic means.
Currently, there is no established categorization that
suﬃciently represents the range of described experimental
manipulations beyond high-level semantic and grammati-
cal classiﬁcations (4,5) or description of techniques (6).
For example, the closest concept we have found is ‘altered
expression,’ deﬁned as ‘altered expression level of a gene/
protein’ (7). We believe that this concept is overly speciﬁc
and fails to cover important phenomena, among others,
changes in protein activity or gene mutations. We pro-
pose, instead, taking the existing concept of ‘perturbation’
and broadening it to comprise the range of terms used in
text to indicate changes in the abundance or activity of
DNA, RNA and proteins. Perturbations, in this new for-
mulation, would refer to a collection of phenomena in a
manner analogous to the way protein–protein interactions
refer to biological phenomena of diﬀerent type (e.g. bind,
activate, inhibit). Since this proposition, like any other,
needs to be tested for validity and utility, we have applied
it to a case study involving gene–phenotype associations in
disease and have developed a mining algorithm that
detects the diverse forms in which perturbations appear
in text. Therefore, we are introducing in this work both
a new way to understand a crucial part of biology and a
new text-mining method tailored to its extraction.
MATERIALS AND METHODS
We created three corpora that we named ‘design’,
‘test’ and ‘analysis’. As initial step, we created the
design corpus to develop an analytical framework
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challenges in the annotation process and to reﬁne guide-
lines that would help the annotators in choosing their
evaluations. Annotating perturbations requires at times
thorough knowledge of experimental biology, which can
only be captured and organized within a solid framework.
Therefore we sought to perform a preliminary analysis on
a test corpus to improve on subsequent annotations. The
design corpus was not used for any other purpose. This
corpus was limited to sentences that included disease-
related gene–phenotype relationships. Using the semantic
relationship nomenclature of Tsai et al. (8), we selected
reports in which the ‘agent’ that deliberately performs
an action is represented by a gene or protein, and the
‘patient’ that is the recipient of the action corresponds
to disease phenotypes. The information we sought
stands in contrast to associative relationships, such as ele-
vated protein levels correlating with disease activity.
To create the design corpus, our initial query matched
Medline sentences containing ordered triplets of a gene or
protein name, a causative verb and a phenotype related to
cancer or diabetes. Each member of the triplet was sepa-
rated within the sentence by a maximum of three words.
The retrieval was performed using Linguamatics I2E
version 3.0 (Cambridge, UK). This software package has
the ability to retrieve sentences from text that include
word patterns established by user queries. The queries
may include both syntactic and semantic constructs.
Semantically, term classes can be deﬁned combining exter-
nal ontologie and adding term morphological variations
and regular expression patterns. Syntactically, it recog-
nizes part-of-speech and shallow parsing constructs such
as noun phrases, verbs and prepositions. In terms of
scope, queries can be conﬁned to diﬀerent document or
text sections, including abstracts, titles or sentences.
For example, a sentence-level query may comprise a
term class protein, a list of verbs (I2E can automatically
generate morphological variants) and a list of phenotype
objects. The gene/protein thesaurus was internally devel-
oped and based on BioThesaurus (9). Forty verbs that
signal causality (e.g. inhibition, stimulation) were com-
piled manually, as was a set of disease-related phenotypes
relevant to cancer (e.g. tumorigenesis, vascularization)
and diabetes (e.g. serum glucose levels, weight gain).
A set of 100 retrieved sentences and relationships were
annotated by three PhD-level evaluators for relevance and
direction of perturbation (see Table 1 for examples).
‘Relevance’ annotation was used to mark relationships
that should be eliminated from the corpus for being irrel-
evant to the intent of the retrieval query, e.g. if the gene
was not acting as an agent. ‘Direction’ indicated the type
of perturbation (increased, decreased or unknown) rela-
tive to the starting state. For example, if a gene is added
back to cells that carry a deletion in that gene to restore
the wild-type state, it is noted as an increase, because the
abundance of the gene was increased relative to the start-
ing state. Sentences were annotated as ‘unknown’ if there
was no stated perturbation, or direction could not be
inferred at the sentence level. It is worth noting that
although an unknown direction could be frequently
resolved by reviewing the abstract or the full text of the
article, we strictly limited our scope to evidence found at
the sentence level.
While most sentences contained straightforward
descriptions of perturbations (e.g. ‘mutations in gene A’
or ‘protein B inhibition’), the broad range of perturbations
in the literature, combined with the complex grammatical
structures found in biomedical text, made some sentence–
relationship pairs diﬃcult to annotate consistently,
mainly due to diﬀerences in knowledge of experimental
Table 1. Examples of relevance and direction annotation
Relevance Direction Sentence Explanation PMID
Irrelevant Diﬀerent members of bcl-2 family may promote or inhibit
apoptosis by synthesizing anti- and proapoptotic
proteins
Members of a gene family, not a gene,
are causing apoptosis phenotype
17404013
Irrelevant The ATF6 and IRE1 pathways cooperatively caused
apoptosis via induction of CHOP, activation of XBP1
and phosphorylation of JNK, and the PERK-eIF2a
pathway counteracted the proapoptotic processes
Pathways, not genes, are causing apop-
tosis phenotype
17464326
Irrelevant This result suggests that toxic products such as reactive
oxygen species and aldehydes liberated by the action of
polyamine oxidase on the acetylated polyamines formed
by SSAT may enhance tumor development
Metabolites, not proteins that generate
them, are causing tumor development
phenotype
17675337
Relevant Unknown These results indicate that survivin is important for
optimal development of bovine blastocysts and conﬁrm
that survivin expression suppresses apoptosis of
pre-implantation embryos
‘Survivin expression’ does not indicate if
there is a state change in amount
17075833
Relevant Increase Finally, we showed that after 7–9 days of incubation,
MCH also inhibits proliferation of non-stimulated
PBMC
‘Incubation’ indicates MCH was added
exogenously
17537530
Relevant Increase Taken together, LDM induces apoptosis in a
p53-dependent manner when given at low doses, but in
a p53-independent manner when given at high doses
‘Given at low doses’ indicates LDM was
added exogenously
17534142
Relevant Decrease Soluble Flt-1 abolished hypoxia/VEGF-induced
hyperpermeability
Soluble forms of receptors create inactive
complexes
17311300
772 Nucleic Acids Research, 2009, Vol. 37,No. 3descriptions and settings by the evaluators. When inter-
annotator agreement proves to be challenging, other
groups have adopted strategies to further improve the
ﬁnal gold standard annotation set (10). For this work,
sentences deemed diﬃcult to evaluate were set aside for
later annotation by discussion and group consensus.
Therefore, the gold standard was comprised of annota-
tions with three-way agreement from the individual assess-
ment, plus the consensus annotations. When each
evaluator’s set of ‘straightforward’ independent annota-
tions (n=237 out of 300 annotations, 79%) was com-
pared to the gold standard, agreement averaged 92.9%.
Sentence–relationships for which there was no agreement
or only two-way agreement were discussed and annotated
by consensus (14%, n=14). While overall inter-annotator
agreement cannot be measured with the annotation pro-
cedure devised, the agreement metrics described are help-
ful as proxies to the level of ambiguity of the task. Pairs
that are only evaluated by consensus diﬀer from the rest
largely in the knowledge required from the evaluator to
elucidate the annotation, rather than in the factual ambi-
guity of the sentence. Hence, discussion and consensus
assessment of pairs yields a better annotation set than
individual annotation. An agreement of 92.9% can be con-
sidered high for the task. Only 7% (n=7) of sentence–
relationship pairs were marked irrelevant.
Following the same guidelines, we created the test
corpus. Each of the three evaluators assessed diﬀerent
sets of 500 sentence–relationship pairs, 250 for diabetes
and 250 for cancer. Sentences deemed not straightforward
were left without annotation (n=126, 8.4%) and later
annotated by consensus. Only 6.3% of all relationships
(n=95) were considered irrelevant, demonstrating the
high precision of the retrieval query. Overall, the proce-
dure used to construct the corpus assured high quality to
the 1405 sentence–relationship annotation. Genes were
mapped to standard nomenclature using our protein/
gene thesaurus. We measured the accuracy of this map-
ping using 250 sentences from the corpus. Accuracy
was 89%.
We performed detection of increased, decreased or
unknown perturbations using machine learning techni-
ques. For that purpose, we constructed a vector of fea-
tures for each relationship–sentence pair using the test
corpus above. The vector was composed of diﬀerent sets
of features. One of them represented token presence as a
binary vector of token weights wi, d={w1,...,w|T|}, where
T is the set of sentence tokens: a weight has value 1 if the
token is present in the sentence and value 0 otherwise, an
approach called set of words (SOW) (11). Tokens were
created by stemming and tokenization of the sentence
words. Hyphenated names were considered both as
single and separate tokens in the SOW in order to capture
aﬃxes like ‘anti-.’ Since proximity to the gene name can be
important in determining a token’s role in describing a
perturbation, the sentence was further divided in several
sections relative to the gene name’s position. Each section
was characterized by a set of features using SOW. The
sections considered were: n tokens before the gene name,
where n={5, 10, all}, and n tokens after the gene name,
where n={10, all}. We noted that many perturbation
descriptions were adjacent or very close to the gene
name (e.g. ‘overexpression of p53’). Hence, we included
a feature with the distance between the gene name and the
beginning of the sentence (e.g. distance of 0 or 1 may
indicate that the perturbation is unknown, e.g. ‘TNF-a
induces apoptosis...’ or ‘The p53 gene...’). We also cre-
ated a set of features using a small perturbation ontology
developed independently over a disease-agnostic set of
retrieved sentences. If a member of the ontology was pres-
ent in the sentence a feature was added with value 1, oth-
erwise with value 0. All the feature sets described were
integrated in a single feature vector for each sentence.
An algorithm based on the principles of maximum
entropy (12, http://homepages.inf.ed.ac.uk/s0450736/
maxent_toolkit.html) was trained using 80% of the test
corpus, randomly sampled from the cancer and diabetes
sets, and tested over the remaining 20% (results were aver-
aged over 10 runs). The training allowed the algorithm to
predict the presence of a perturbation and its direction.
Performance measures were evaluated and compared
favorably to an SVM algorithm (13).
To create the analysis corpus, we extended the scope of
our methodology used to retrieve the test corpus by elim-
inating the disease-speciﬁc phenotype constraints in the
retrieval query (hence, phenotypes were not included in
the query). We applied the query to Medline diabetes
abstracts after 1996 and retrieved 359385 relationships
related to diﬀerent conditions and phenotypes. This
output was run through the machine-learning algorithm
to create a wide-scope, disease-agnostic set of 191240 per-
turbation predictions. To create a diabetes-speciﬁc subset,
only sentences from Medline abstracts containing the
word diabetes in their MeSH descriptors were included.
RESULTS
There were signiﬁcant diﬀerences both in technique and
direction between the cancer and diabetes perturbations in
the test corpus, with decreased perturbations more preva-
lent in cancer. Table 2 shows the performance of the
Table 2. Perturbation extraction performance
Count Precision (%) Recall (%) F-measure (%)
Perturbation 690 79.2 79.8 79.4
No ontology 76.4 79.6 77.6
Only ontology 77.2 59.5 67.0
Straightforward 83.3 78.9 81.0
Increased 436 75.3 71.1 72.9
No ontology 76.6 69.9 72.9
Only ontology 65.7 50.9 56.8
Straightforward 77.7 68.8 72.7
Decreased 254 79.0 65.1 71.2
No ontology 78.5 63.6 70.0
Only ontology 79.8 58.4 66.4
Straightforward 80.4 67.2 72.9
Precision, recall and macro-averaged F-measure were calculated using
four diﬀerent combinations of feature sets: ‘full’, ‘no ontology’, ‘only
ontology’ and ‘straightforward’. Baseline frequencies were 32.8% for
increased perturbations and 18.1% for decreased perturbations.
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combinations of feature sets. Our algorithm detected per-
turbations with F-measure of 79.4%. Detection of
increased and decreased perturbations had a lower
F-measure, 72.9% and 71.2%, respectively. When we
excluded the perturbation ontology in feature generation,
results were only slightly lower, whereas when we exclu-
sively used the perturbation ontology, results were much
lower, notably due to reduced recall. ‘Straightforward’
relationships (91.6% of the total) were those that evalua-
tors annotated without consultation with other annota-
tors. These relationships were less challenging for
humans, and the algorithm had better performance over
this subset than overall. Due to absence of previous work
in perturbation detection, these results cannot be com-
pared, but they fall in ranges typical of other successful
biomedical text mining tools.
To determine whether the disease impacted the fre-
quency of perturbation types, we compared cancer and
diabetes literature. The diabetes literature was signiﬁ-
cantly enriched in increased perturbations, whereas the
cancer literature showed an even distribution between
increased and decreased perturbations. In cancer, more
perturbations were performed with antisense oligonucleo-
tide (n=9), antibody (n=16) and RNA interference
(n=26) than in diabetes (antisense, n=3; antibody,
n=2; RNAi, n=0). Perturbations in diabetes were
more frequently described as injections (n=132) and/or
administered by dose (n=57) than in cancer (dose, n=3;
injection, n=6). Perturbations in cancer were also more
frequently described as being in vivo (n=12) or in vitro
(n=14) than in diabetes (in vivo, n=5; in vitro, n=0).
We examined the sentences for frequently occurring terms,
grouped by their level of regulation (i.e. protein, mRNA
or DNA), if known. Table 3 illustrates the wide variation
in terms and aﬃxes used in both diseases. Many of the
terms related to dosing and routes of administration (e.g.
administration, intracerebroventricular, injection) show a
strong dominance in the diabetes literature compared to
the cancer literature. Although these usually indicate an
increasing perturbation, there can be exceptions, such as
systemic delivery of an inhibitor.
Table 3. Ontology occurrence count in sentences from the test corpus, separated by diabetes and cancer phenotypes
Gene and protein perturbations Cancer Diabetes Cancer Diabetes
Total increasing modiﬁcations 266 586 Total decreasing modiﬁcations 267 110
General increasing modiﬁcations General decreasing modiﬁcations
Activation 66 12 Down-regulated, -ion 12 0
Administered, -ion 7 120 Inactivation 5 0
Dose, -age, -dependent 11 86 Inhibition 30 7
Ectopic 7 0 Repression 1 0
Enhanced ... expression 10 0 Suppression 10 3
Exogenous 6 23 DNA decreasing modiﬁcations
i.c.v. 0 11 Deﬁciency, -ent 15 12
i.p. 0 7 Deletion 3 2
Increased 26 18 Dominant-negative 3 0
Induction 8 2 Knockout 1 2
Infused, -ion 0 35 Loss 12 13
Injected, -ion 7 66 Mutant 0 0
Intracerebroventricular 0 51 Mutated, -ion 0 3
Intraperitoneal 1 16 mRNA decreasing modiﬁcations
mg/kg,/kg 0 8 Anti(-)sense 9 3
Oral 6 4 Interference 5 1
Overexpressed, -ration 38 0 Interfering RNA 2 0
Peripherally 0 7 Knockdown 12 0
Recombinant 7 10 RNA interference 4 0
Restoration 2 0 RNAi 2 0
Subcutaneous 0 2 Short hairpin RNA 1 0
Systemic 1 9 Silenced 1 0
Treatment 24 22 siRNA 15 0
Up-regulation 8 0 Protein decreasing modiﬁcations
DNA increasing modiﬁcations Antagonist 7 28
Adenoviral 2 1 Anti- 25 4
Adenovirus 0 0 Antibody, -ies 11 3
Gain-of-function 2 0 Blockade, -ing 12 8
Gene delivery 1 3 Deactivation 1 0
Transgenic 3 2 Decoy 2 0
mRNA increasing modiﬁcations Fc- 0 0
Inducible 2 0 Inhibitor 53 15
Protein increasing modiﬁcations Inverse agonist 0 1
Activator 10 0 mAbs 1 0
Agonist 9 54 Neutralization 1 0
Analog/analogue 2 7 Reduced ... activity 1 5
Soluble 4 0
Targeting 6 0
Note that total increased and decreased perturbations exceeds values in Table 2 since multiple perturbation terms may appear in a single sentence.
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prevalence in the literature without regard to their use
in vivo or in vitro. For instance, in diabetes a change in
blood glucose levels signals a change in disease state—
clearly a phenotype monitored following perturbation
in vivo. Likewise, in cancer a change in the number of
metastases is exclusively described in in vivo systems. In
contrast, insulin sensitivity can be used to describe both
in vivo and in vitro systems. For cancer, cell proliferation
and apoptosis rates are also described both in vivo and
in vitro.
If our hypothesis that perturbed genes and proteins
form the underpinnings of disease mechanisms, these enti-
ties should be well represented in pathway diagrams
and among drug candidates. We applied our trained algo-
rithm to a set of 14345 sentence–relationship facts for
genes from our analysis corpus belonging to a diabetes
pathway (Figure 1). Predictably, our algorithm found a
strong correlation between the number of Medline
abstracts in which a gene is mentioned and the number
of times it is described as perturbed (r
2=0.70). The
results in Figure 1 show the diﬀerence in intensity and
modality in which each gene is described or pursued
experimentally. Some genes were typically more increased
or decreased, often reﬂecting their roles in therapeutics.
Examples of signiﬁcantly (P<10
6) increased were insu-
lin, interleukin 2 or parathyroid hormone. Among the
decreased were such genes as epidermal growth factor
receptor; caspase 8 and plasminogen activator, urokinase
receptor.
We compared detected perturbation counts from the
analysis corpus against the gene–disease associations
included in the OMIM Morbid Map (OMIM online refer-
ence, http://www.ncbi.nlm.nih.gov/omim/). The average
Figure 1. Perturbations extracted from genes involved in the Diabetes Mellitus Type II pathway in the Kyoto Encyclopedia of Genes and Genomes
(21). Diﬀerences in perturbation direction are large for some members of the pathway, note that the scale bar is logarithmic.
Nucleic AcidsResearch, 2009, Vol.37,No. 3 775abstract mention and gene perturbation counts were
higher for genes with MorbidMap associations (t-test,
P<10
4). This was consistent with our expectation that
genes associated to disease would be the subject of deeper
study. However, genes that had been perturbed numerous
times were not necessarily linked to disease. For example,
out of the 100 most perturbed genes, 54 were not linked to
disease in OMIM MorbidMap, including at the top such
genes as jun oncogene, interleukin 4, ﬁbroblast growth
factor 2 (basic), colony stimulating factor 2 (granulo-
cyte–macrophage), colony stimulating factor 3 (granulo-
cyte) and mitogen-activated protein kinase 3.
DISCUSSION
Perturbations are relevant for areas like the study of gene–
disease associations, protein–protein interactions (PPI) or
gene regulatory networks. Gene–disease association
extraction studies have largely focused on simply detecting
associations rather than characterizing them (7,14). PPI
and gene regulation extraction studies have side-stepped
perturbation types, without considering anything further
than the experimental technique (15,16). We note that PPI
relationships are frequently devoid of perturbations and
the focus is on how a PPI was detected, which does not
necessarily involve a causative relationship. The
Proteomics Standards Initiative – Molecular Interactions
(PSI-MI) ontology (6) is a comprehensive eﬀort to
describe molecular interactions. This ontology, while
including a detailed experimental preparation section,
lacks expressivity in describing perturbations generically.
Similarly to Bundschus et al. (7), it includes a section on
expression level with entries ‘under expressed’, ‘over
expressed’ and ‘physiological’.
The lack of a general framework for recognizing, char-
acterizing and classifying perturbations is surprising when
one considers their importance in phenomena encountered
experimentally. Researchers with interest in characterizing
previous and current perturbation work on a biological
system face the challenge of a naturalist trying to deal
with animal species without a Linnaean taxonomy. This
is reﬂected in the methodological landscape that was set in
the early literature in the ﬁelds of biomedical ontologies
and text mining. For example, the comprehensive text
mining tool MedLEE (17) only considered the ‘state’ of
a gene or protein, where the state has an adjectival role
such as ‘mutated’ in the phrase ‘mutated X’. Perturbation
descriptions, however, should be considered carefully.
Observe the diﬀerences between the sentences (i) ‘X acti-
vates Y.’ and (ii) ‘Inhibition of X activates Y’. From the
point of view of classic PPI extraction both relationships
are equivalent and can be represented with the triplet X
activate Y. The perturbation in sentence (ii), however, sig-
nals that it is likely that protein X is inhibiting protein Y
instead. We have called this phenomenon ‘reversal’. Given
the results of the present assessment, a review of the rela-
tionship data available should be considered under this
model.
We have focused our methodology in gene–phenotype
associations in disease but the principles shown are
applicable to other well-known areas, such as PPI, as
well as less explored ones such as identiﬁcation of biomar-
kers or cellular processes. A perturbation taxonomy, like
the one described in Table 4, could capture the diﬀerent
dimensions that may be of interest to the inquiring scien-
tist. This taxonomy has four annotation types: relevance,
direction, molecule and eﬀect. Relevance annotation
marks relationships that are irrelevant to the intent of
the retrieval query. Direction distinguishes between per-
turbations that represent an increase or a decrease over
starting levels. Unknown direction annotation is intended
for perturbations whose direction cannot be inferred at the
sentence level. Molecule annotation characterizes the type
of molecule being primarily aﬀected by the perturbation:
gene, RNA or protein. Expression annotation is used for a
change of expression level without clarifying whether the
change is in RNA or protein. Eﬀect annotation diﬀerenti-
ates between changes in activity or function and changes
in abundance. The following examples illustrate these
annotations: A gene mutation is a decrease in gene activ-
ity, where the function/activity of a gene is speciﬁcally
understood as making a wild-type transcript. Exogenous
addition of a gene via viral transfection, plasmid transfor-
mation, etc., is an increase in gene abundance. A gene
duplication is an increase in gene abundance while a
knockout is a decrease in gene abundance. Dominant neg-
ative is a mutation in a gene, which indicates that, com-
pared to wild-type, it has defective function. Silencing,
knock-down and antisense all apply to a decrease in
RNA abundance. An antibody blocking a protein
decreases the protein activity or function. Interfering
with a protein binding another protein is a decrease on a
protein’s function or activity. Treatment, incubation,
recombination, or synthetic refer to exogenous addition
of protein.
Perturbations evolve, notably as new techniques are
developed and targets are identiﬁed. We expect perturba-
tions to be subject to trends and popularity variations
similar to those in other aspects of biomedicine (18–20).
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Table 4. Proposed annotation guidelines
Relevance Direction Molecule Eﬀect
Relevant Increase Gene Activity
Irrelevant Decrease RNA Abundance
Unknown Protein expression
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